Vaccine biotech Inventprise has developed technology that offers broader protection than currently available products. Its lead program, a pneumococcal vaccine candidate, is being readied for tests in humans and it now has a financial commitment of up to $90 million from the Bill & Melinda Gates Foundation.
VisualDx got a grant for $655,535 from the Bill and Melinda Gates Foundation to build a tool that can allow health workers to diagnose skin conditions without a signal. The app uses images and a series of questions to point users toward a diagnosis.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The new fund follows a $200 million fund raised two years ago and will go to diagnostics, therapeutics, R&D and clinical care. New partner Mike Pool will be focused on neuroscience investments.
Gates will invest $50 million in the Dementia Discovery Fund. This will be followed by another $50 million investment in startups working on Alzheimer's research.
Also, research scientists have developed a way to deliver drugs through the placenta and what risks does the UK life science community face with an exit from the European Union?
The new Seattle-based firm Biomatics Capital Partners is led by Boris Nikolic, a science advisor to Bill Gates. It is raising $150 million.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The startup's underlying research has been backed by the Gates Foundation since 2014.
TOP STORIES The Bill and Melinda Gates Foundation is investing up to $75 million in a network of disease surveillance sites in developing countries to rapidly gather better data, about how, where and why children are getting sick and dying, according to a statement from the foundation. The Child Health and Mortality Prevention Surveillance Network […]